These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
133 related articles for article (PubMed ID: 9572482)
21. The regulatory mechanism of phosphatidylinositol 3-kinase by insulin in 3T3 L1 fibroblasts: phosphorylation-independent activation of phosphatidylinositol 3-kinase. Kang I; Choi SL; Kim SS; Kim SJ; Ha J; Oh SM; Kim SS Exp Mol Med; 1998 Dec; 30(4):263-9. PubMed ID: 9894159 [TBL] [Abstract][Full Text] [Related]
22. Lovastatin disrupts early events in insulin signaling: a potential mechanism of lovastatin's anti-mitogenic activity. McGuire TF; Xu XQ; Corey SJ; Romero GG; Sebti SM Biochem Biophys Res Commun; 1994 Oct; 204(1):399-406. PubMed ID: 7524501 [TBL] [Abstract][Full Text] [Related]
24. Adenovirus-mediated overexpression of IRS-1 interacting domains abolishes insulin-stimulated mitogenesis without affecting glucose transport in 3T3-L1 adipocytes. Sharma PM; Egawa K; Gustafson TA; Martin JL; Olefsky JM Mol Cell Biol; 1997 Dec; 17(12):7386-97. PubMed ID: 9372969 [TBL] [Abstract][Full Text] [Related]
25. Insulin-induced in situ phosphorylation of the insulin receptor located in the plasma membrane versus endosomes. Wang B; Balba Y; Knutson VP Biochem Biophys Res Commun; 1996 Oct; 227(1):27-34. PubMed ID: 8858098 [TBL] [Abstract][Full Text] [Related]
26. The type 2 vascular endothelial growth factor receptor recruits insulin receptor substrate-1 in its signalling pathway. Senthil D; Ghosh Choudhury G; Bhandari BK; Kasinath BS Biochem J; 2002 Nov; 368(Pt 1):49-56. PubMed ID: 12153400 [TBL] [Abstract][Full Text] [Related]
27. Insulin receptor substrates form high-molecular-mass complexes that modulate their availability to insulin/insulin-like growth factor-I receptor tyrosine kinases. Fukushima T; Arai T; Ariga-Nedachi M; Okajima H; Ooi Y; Iijima Y; Sone M; Cho Y; Ando Y; Kasahara K; Ozoe A; Yoshihara H; Chida K; Okada S; Kopchick JJ; Asano T; Hakuno F; Takahashi S Biochem Biophys Res Commun; 2011 Jan; 404(3):767-73. PubMed ID: 21168390 [TBL] [Abstract][Full Text] [Related]
28. The protein-tyrosine kinase fer associates with signaling complexes containing insulin receptor substrate-1 and phosphatidylinositol 3-kinase. Iwanishi M; Czech MP; Cherniack AD J Biol Chem; 2000 Dec; 275(50):38995-9000. PubMed ID: 11006284 [TBL] [Abstract][Full Text] [Related]
29. Comparison of the effects of insulin, PDGF, interleukin-6, and interferon-gamma on glucose transport in 3T3-L1 cells: lack of cross-talk between tyrosine kinase receptors and JAK/STAT pathways. Huppertz C; Schwartz C; Becker W; Horn F; Heinrich PC; Joost HG Diabetologia; 1996 Dec; 39(12):1432-9. PubMed ID: 8960823 [TBL] [Abstract][Full Text] [Related]
30. The insulin receptor substrate (IRS-1) is a PEST protein that is susceptible to calpain degradation in vitro. Smith LK; Bradshaw M; Croall DE; Garner CW Biochem Biophys Res Commun; 1993 Oct; 196(2):767-72. PubMed ID: 8240352 [TBL] [Abstract][Full Text] [Related]
32. Activation of PI 3-kinase in 3T3-L1 adipocytes by association with insulin receptor substrate-1. Lamphere L; Carpenter CL; Sheng ZF; Kallen RG; Lienhard GE Am J Physiol; 1994 Mar; 266(3 Pt 1):E486-94. PubMed ID: 7513124 [TBL] [Abstract][Full Text] [Related]
33. FALDH reverses the deleterious action of oxidative stress induced by lipid peroxidation product 4-hydroxynonenal on insulin signaling in 3T3-L1 adipocytes. Demozay D; Mas JC; Rocchi S; Van Obberghen E Diabetes; 2008 May; 57(5):1216-26. PubMed ID: 18174527 [TBL] [Abstract][Full Text] [Related]
34. C-terminal Src kinase (CSK) modulates insulin-like growth factor-I signaling through Src in 3T3-L1 differentiation. Sekimoto H; Boney CM Endocrinology; 2003 Jun; 144(6):2546-52. PubMed ID: 12746317 [TBL] [Abstract][Full Text] [Related]
36. The effect of glucose concentration on insulin-induced 3T3-L1 adipose cell differentiation. Gagnon A; Sorisky A Obes Res; 1998 Mar; 6(2):157-63. PubMed ID: 9545023 [TBL] [Abstract][Full Text] [Related]
37. Pioglitazone promotes insulin-induced activation of phosphoinositide 3-kinase in 3T3-L1 adipocytes by inhibiting a negative control mechanism. Sizer KM; Smith CL; Jacob CS; Swanson ML; Bleasdale JE Mol Cell Endocrinol; 1994 Jul; 103(1-2):1-12. PubMed ID: 7525381 [TBL] [Abstract][Full Text] [Related]
38. Pioglitazone ameliorates tumor necrosis factor-alpha-induced insulin resistance by a mechanism independent of adipogenic activity of peroxisome proliferator--activated receptor-gamma. Iwata M; Haruta T; Usui I; Takata Y; Takano A; Uno T; Kawahara J; Ueno E; Sasaoka T; Ishibashi O; Kobayashi M Diabetes; 2001 May; 50(5):1083-92. PubMed ID: 11334412 [TBL] [Abstract][Full Text] [Related]
39. Growth hormone and fibronectin expression in 3T3 preadipose cells. Guller S; Allen DL; Corin RE; Lockwood CJ; Sonenberg M Endocrinology; 1992 May; 130(5):2609-16. PubMed ID: 1572284 [TBL] [Abstract][Full Text] [Related]
40. Phosphatidylinositol 3-kinase and protein kinase D1 specifically cooperate to negatively regulate the insulin-like growth factor signaling pathway. Karam M; Lassarre C; Legay C; Ricort JM Biochim Biophys Acta; 2012 Feb; 1823(2):558-69. PubMed ID: 22227580 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]